30 Participants Needed
Medical College of Wisconsin logo

Sodium Supplementation for Premature Birth

JS
EA
Overseen ByElizabeth Awe, BA
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 6 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this project is to determine the direct impact of sodium supplementation in preterm infants and to see the overall improvement of their growth and health status. from this study will help us develop a better treatment for in the future.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it mentions that infants using diuretics (medications that help remove excess fluid) at the start of the study may need to wait or be re-evaluated.

What data supports the effectiveness of sodium supplementation as a treatment for premature birth?

Research shows that sodium supplementation in very low birth weight preterm infants can significantly improve growth rates, such as weight, length, and head circumference, without causing harmful sodium imbalances. This suggests that sodium supplementation may help support healthy development in premature infants.12345

Is sodium supplementation safe for premature infants?

Sodium supplementation in premature infants appears to be generally safe, with studies showing no significant adverse effects like hypernatremia (high sodium levels) or renal failure. It can improve growth and biochemical status without causing undesirable side effects, although careful monitoring is necessary to avoid complications.12356

How does sodium supplementation differ from other treatments for premature birth?

Sodium supplementation for premature infants is unique because it specifically addresses sodium deficiency, which is common in these infants due to high renal sodium losses. This treatment improves growth and biochemical status without causing undesirable side effects, unlike other treatments that may not target sodium balance directly.12567

Research Team

JS

Jeffrey Segar, MD

Principal Investigator

Medical College of Wisconsin

Eligibility Criteria

This trial is for preterm infants with a birth weight over 500 grams, born between 25 and less than 30 weeks of gestation, and who are younger than 14 days old at the time they join. Infants with major birth defects, kidney problems indicated by high creatinine levels, or those on diuretics can't participate unless their condition stabilizes.

Inclusion Criteria

Birthweight >500 grams
I am between 25 and 30 weeks pregnant.
I am less than 14 days old.

Exclusion Criteria

I have a structural issue with my urinary system.
I am using diuretics and can pause for the study's initial 2 weeks.
Non-English speaking parents
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2 weeks

Treatment

Participants are randomized into two groups: one receiving sodium supplementation based on a urine sodium concentration algorithm, and the other managed by current standards. Nutritional and health data are collected.

8 weeks
Weekly visits for sodium level assessment and data collection

Follow-up

Participants are monitored for safety and effectiveness after treatment, including microbiome diversity and weight gain.

4 weeks

Treatment Details

Interventions

  • Sodium algorithm
Trial Overview The study is testing how adding sodium to the diets of premature babies affects their growth and gut bacteria. Researchers will use an algorithm to decide how much sodium these babies need. The goal is to find out if this helps them grow better.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Sodium algorithmExperimental Treatment1 Intervention
Starting at 2 weeks of age, the sodium algorithm group will be started based on their sodium levels. This will be adjusted weekly based on weight gain and sodium levels.
Group II: ControlActive Control1 Intervention
Subjects will be cared for by current protocols

Sodium algorithm is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:

🇪🇺
Approved in European Union as Sodium chloride for:
  • Hyponatremia correction
  • Fluid resuscitation
  • Electrolyte imbalance
🇺🇸
Approved in United States as Sodium chloride for:
  • Hyponatremia correction
  • Fluid resuscitation
  • Electrolyte imbalance
🇨🇦
Approved in Canada as Sodium chloride for:
  • Hyponatremia correction
  • Fluid resuscitation
  • Electrolyte imbalance
🇯🇵
Approved in Japan as Sodium chloride for:
  • Hyponatremia correction
  • Fluid resuscitation
  • Electrolyte imbalance
🇨🇳
Approved in China as Sodium chloride for:
  • Hyponatremia correction
  • Fluid resuscitation
  • Electrolyte imbalance
🇨🇭
Approved in Switzerland as Sodium chloride for:
  • Hyponatremia correction
  • Fluid resuscitation
  • Electrolyte imbalance

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical College of Wisconsin

Lead Sponsor

Trials
645
Recruited
1,180,000+

Findings from Research

The implementation of a clinical practice algorithm for sodium supplementation in preterm infants led to a significant increase in average daily sodium intake, with 75% of infants in the 2016 cohort requiring supplementation within the first 4 weeks after birth.
Growth outcomes improved in the 2016 cohort, as indicated by a greater change in weight Z-score compared to the 2014-2015 cohort, although there was no observed impact on respiratory status.
Physiological Approach to Sodium Supplementation in Preterm Infants.Segar, DE., Segar, EK., Harshman, LA., et al.[2019]
Sodium supplementation in 41 very low birth weight preterm infants led to significant increases in weight gain, length gain, and head circumference over a six-week period, compared to a control group of 25 infants.
Despite high renal excretion of sodium in the supplemented group, there were no cases of hypernatremia or hyponatremia, indicating that sodium supplementation is safe and may positively influence growth rates through its effects on bone and protein metabolism.
Sodium supplementation in very low birth weight infants fed on their own mothers milk I: Effects on sodium homeostasis.Ayisi, RK., Mbiti, MJ., Musoke, RN., et al.[2013]
In a study of 17 premature infants, restricting sodium intake during the first few days of life significantly reduced the risk of hypernatremia and the need for large fluid volumes, compared to those receiving maintenance sodium.
Sodium-restricted infants had a lower incidence of bronchopulmonary dysplasia, suggesting that this approach may improve outcomes in very low birth weight babies without increasing mortality.
Sodium restriction versus daily maintenance replacement in very low birth weight premature neonates: a randomized, blind therapeutic trial.Costarino, AT., Gruskay, JA., Corcoran, L., et al.[2019]

References

Physiological Approach to Sodium Supplementation in Preterm Infants. [2019]
Sodium supplementation in very low birth weight infants fed on their own mothers milk I: Effects on sodium homeostasis. [2013]
Sodium restriction versus daily maintenance replacement in very low birth weight premature neonates: a randomized, blind therapeutic trial. [2019]
[Sodium balance in premature infants]. [2013]
[Developmental physiologic aspects of volume and sodium regulation in premature and mature newborn infants]. [2013]
Sodium homeostasis in term and preterm neonates. III. Effect of salt supplementation. [2019]
Effect of High Sodium Intake (5 mEq/kg/day) in Preterm Newborns ( [2023]